1. Scrip
  2. >>Focus On Asia
  3. >>South Korea

What Would It Take To Attract Global Pharmas To Korea?

 
• By Jung Won Shin

What do successful biopharma countries have in common? At a recent biopharma industry seminar in Incheon, South Korea, delegates stressed the importance of creating strong bioclusters if the country is to transform itself into a biopharma-focused nation.

Incheon_South Korea_1200x675
Incheon, South Korea

Participants in a recent biopharma seminar in Songdo, Incheon, called for the creation of a "biopharma specialized district" to bring together manufacturing, R&D and marketing capabilities in the metropolitan city using the successful strategies of other countries as a benchmark.

South Korea needs to build "ready to invest" environment, designating a pilot industrial complex area, supported by the government, to create bioclusters to rival Singapore's

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

 
• By Jung Won Shin

DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.

Korea State R&D Fund Seeks Continuity To Enable Seamless Support

 
• By Jung Won Shin

The CEO of a South Korean state-run drug R&D support fund urges the renewal of the initiative as it increasingly focuses on new modalities and novel targets.

Korean Biotech Roundup: GNT Set For First Direct Korean Biopharma IPO On Nasdaq

 
• By Jung Won Shin

GNT Pharma prepares for the first listing of a Korean biotech on Nasdaq, while others sign major global out-licensing deals with large multinational partners.

US Tariff Impact On Korea Dissected As Country Gears For Presidential Election

 
• By Jung Won Shin

Analysts expect a limited impact on South Korean pharma from US tariffs, even if imposed at a later date. Meanwhile, the early June domestic presidential election is set to determine the direction of policies in the sector.

More from Focus On Asia